[{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 538)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":538,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":20.3,"TPM_sd":22.46,"TPM_min":1.04,"TPM_25th_percentile":5.47,"TPM_median":11.71,"TPM_75th_percentile":26.09,"TPM_max":180.54},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 168)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":168,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":14.48,"TPM_sd":17.02,"TPM_min":0,"TPM_25th_percentile":5.4,"TPM_median":10.1,"TPM_75th_percentile":17.81,"TPM_max":149.86},{"x_label":"Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 43)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":43,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Adamantinomatous Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000069","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":11.19,"TPM_sd":17.9,"TPM_min":2.37,"TPM_25th_percentile":5.73,"TPM_median":7.8,"TPM_75th_percentile":9.14,"TPM_max":118.18},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 45)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":45,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":11.57,"TPM_sd":18.31,"TPM_min":2.63,"TPM_25th_percentile":4.98,"TPM_median":6.58,"TPM_75th_percentile":9.61,"TPM_max":117.84},{"x_label":"Chordoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Chordoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0008978","MONDO":"MONDO_0008978","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.32,"TPM_sd":1.15,"TPM_min":3.45,"TPM_25th_percentile":3.46,"TPM_median":3.89,"TPM_75th_percentile":4.61,"TPM_max":6.19},{"x_label":"Choroid plexus carcinoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Choroid plexus carcinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016718","MONDO":"MONDO_0016718","GTEx_tissue_subgroup_UBERON":"","TPM_mean":16.99,"TPM_sd":29.19,"TPM_min":2.68,"TPM_25th_percentile":4.77,"TPM_median":5.95,"TPM_75th_percentile":10.02,"TPM_max":97.97},{"x_label":"Choroid plexus papilloma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 23)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":23,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Choroid plexus papilloma","GTEx_tissue_subgroup":"","EFO":"EFO_1000177","MONDO":"MONDO_0009837","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.65,"TPM_sd":3.04,"TPM_min":2.78,"TPM_25th_percentile":5.13,"TPM_median":8.01,"TPM_75th_percentile":9.91,"TPM_max":11.87},{"x_label":"Clear cell sarcoma of the kidney  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Clear cell sarcoma of the kidney","GTEx_tissue_subgroup":"","EFO":"EFO_0000350","MONDO":"MONDO_0005006","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.22,"TPM_sd":0.95,"TPM_min":4.52,"TPM_25th_percentile":5.56,"TPM_median":6.55,"TPM_75th_percentile":6.76,"TPM_max":7.99},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 12)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":12,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":18.05,"TPM_sd":15.9,"TPM_min":4.96,"TPM_25th_percentile":6.99,"TPM_median":12.98,"TPM_75th_percentile":20.16,"TPM_max":52.56},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.78,"TPM_sd":1.58,"TPM_min":2.01,"TPM_25th_percentile":3.52,"TPM_median":4.77,"TPM_75th_percentile":6.14,"TPM_max":7.18},{"x_label":"Diffuse hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 22)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":22,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0016680","GTEx_tissue_subgroup_UBERON":"","TPM_mean":22.3,"TPM_sd":16.37,"TPM_min":7.73,"TPM_25th_percentile":10.55,"TPM_median":20.14,"TPM_75th_percentile":23.76,"TPM_max":66.85},{"x_label":"Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 4)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse intrinsic pontine glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.32,"TPM_sd":2.07,"TPM_min":2.31,"TPM_25th_percentile":2.88,"TPM_median":4.03,"TPM_75th_percentile":5.46,"TPM_max":6.92},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 116)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":116,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":17.01,"TPM_sd":18.18,"TPM_min":0.86,"TPM_25th_percentile":5.62,"TPM_median":8.89,"TPM_75th_percentile":22.92,"TPM_max":86.15},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 31)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":31,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.4,"TPM_sd":4.6,"TPM_min":2.95,"TPM_25th_percentile":5.81,"TPM_median":8.88,"TPM_75th_percentile":11.33,"TPM_max":23},{"x_label":"Embryonal tumor with multilayer rosettes  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Embryonal tumor with multilayer rosettes","GTEx_tissue_subgroup":"","EFO":"MONDO_0016715","MONDO":"MONDO_0016715","GTEx_tissue_subgroup_UBERON":"","TPM_mean":11.6,"TPM_sd":2.26,"TPM_min":9,"TPM_25th_percentile":10.86,"TPM_median":12.71,"TPM_75th_percentile":12.9,"TPM_max":13.09},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 116)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":116,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.11,"TPM_sd":6.71,"TPM_min":0.36,"TPM_25th_percentile":5.27,"TPM_median":6.92,"TPM_75th_percentile":8.9,"TPM_max":58.85},{"x_label":"Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ewing sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000174","MONDO":"MONDO_0012817","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.34,"TPM_sd":4.07,"TPM_min":4.69,"TPM_25th_percentile":7.51,"TPM_median":9.57,"TPM_75th_percentile":12.68,"TPM_max":18.7},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 64)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":64,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.66,"TPM_sd":4.71,"TPM_min":0.95,"TPM_25th_percentile":5.34,"TPM_median":8.25,"TPM_75th_percentile":10.91,"TPM_max":25.97},{"x_label":"Ganglioneuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary Tumors, N = 44)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":44,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Ganglioneuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000502","MONDO":"MONDO_0005035","GTEx_tissue_subgroup_UBERON":"","TPM_mean":21.34,"TPM_sd":11.94,"TPM_min":1.27,"TPM_25th_percentile":12.51,"TPM_median":20.5,"TPM_75th_percentile":25.06,"TPM_max":55.52},{"x_label":"Ganglioneuroblastoma  (Dataset = GMKF, Specimen = Pediatric Primary Tumors, N = 25)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":25,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"GMKF","Disease":"Ganglioneuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000502","MONDO":"MONDO_0005035","GTEx_tissue_subgroup_UBERON":"","TPM_mean":27.53,"TPM_sd":11.29,"TPM_min":10.77,"TPM_25th_percentile":21.12,"TPM_median":23.9,"TPM_75th_percentile":32.43,"TPM_max":55.52},{"x_label":"Ganglioneuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 20)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":20,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Ganglioneuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000502","MONDO":"MONDO_0005035","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.46,"TPM_sd":6.22,"TPM_min":5.03,"TPM_25th_percentile":9.16,"TPM_median":11.54,"TPM_75th_percentile":15.28,"TPM_max":30.45},{"x_label":"Ganglioneuroma  (Dataset = All Cohorts, Specimen = Pediatric Primary Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Ganglioneuroma","GTEx_tissue_subgroup":"","EFO":"EFO_0000500","MONDO":"MONDO_0005033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.49,"TPM_sd":5.57,"TPM_min":6.12,"TPM_25th_percentile":7.36,"TPM_median":8.6,"TPM_75th_percentile":12.68,"TPM_max":16.76},{"x_label":"Germinoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 8)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Germinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0020580","MONDO":"MONDO_0020580","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.28,"TPM_sd":8.06,"TPM_min":3.3,"TPM_25th_percentile":3.34,"TPM_median":4.97,"TPM_75th_percentile":14.43,"TPM_max":25.33},{"x_label":"Glial-neuronal tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 17)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":17,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Glial-neuronal tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0016729","MONDO":"MONDO_0016729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":18.63,"TPM_sd":26.11,"TPM_min":2.21,"TPM_25th_percentile":5.82,"TPM_median":8.09,"TPM_75th_percentile":13.58,"TPM_max":86.91},{"x_label":"Glioblastoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Glioblastoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0018177","MONDO":"MONDO_0018177","GTEx_tissue_subgroup_UBERON":"","TPM_mean":18.31,"TPM_sd":20.55,"TPM_min":4.15,"TPM_25th_percentile":6.52,"TPM_median":8.89,"TPM_75th_percentile":25.39,"TPM_max":41.88},{"x_label":"Hemangioblastoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 4)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Hemangioblastoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016748","MONDO":"MONDO_0016748","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.07,"TPM_sd":0.3,"TPM_min":5.76,"TPM_25th_percentile":5.91,"TPM_median":6.04,"TPM_75th_percentile":6.2,"TPM_max":6.46},{"x_label":"High-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 125)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":125,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0100342","MONDO":"MONDO_0100342","GTEx_tissue_subgroup_UBERON":"","TPM_mean":17.71,"TPM_sd":16.24,"TPM_min":0.95,"TPM_25th_percentile":6.11,"TPM_median":10.7,"TPM_75th_percentile":25.74,"TPM_max":81.59},{"x_label":"Infant-type hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Infant-type hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"EFO_0005543","MONDO":"MONDO_0014695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.02,"TPM_sd":2.34,"TPM_min":2.75,"TPM_25th_percentile":6.6,"TPM_median":7.47,"TPM_75th_percentile":8.55,"TPM_max":9.18},{"x_label":"Langerhans Cell histiocytosis  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 5)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Langerhans Cell histiocytosis","GTEx_tissue_subgroup":"","EFO":"EFO_1000318","MONDO":"MONDO_0018310","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.85,"TPM_sd":0.8,"TPM_min":3,"TPM_25th_percentile":3.16,"TPM_median":3.93,"TPM_75th_percentile":4.21,"TPM_max":4.97},{"x_label":"Low-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 334)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":334,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.12,"TPM_sd":7.09,"TPM_min":1.27,"TPM_25th_percentile":6.04,"TPM_median":7.81,"TPM_75th_percentile":10.37,"TPM_max":88.25},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 206)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":206,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":18.68,"TPM_sd":27.94,"TPM_min":1.59,"TPM_25th_percentile":8.82,"TPM_median":12.06,"TPM_75th_percentile":17.57,"TPM_max":241.56},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 31)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":31,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016642","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":7.61,"TPM_sd":5.48,"TPM_min":3.16,"TPM_25th_percentile":5.04,"TPM_median":6.17,"TPM_75th_percentile":8.61,"TPM_max":33.84},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary Tumors, N = 304)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":304,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":29.06,"TPM_sd":18.32,"TPM_min":2.63,"TPM_25th_percentile":13.48,"TPM_median":24.7,"TPM_75th_percentile":43.16,"TPM_max":88.29},{"x_label":"Neuroblastoma  (Dataset = GMKF, Specimen = Pediatric Primary Tumors, N = 183)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":183,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"GMKF","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":40.88,"TPM_sd":15.38,"TPM_min":9.04,"TPM_25th_percentile":29.35,"TPM_median":39.7,"TPM_75th_percentile":49.88,"TPM_max":89.91},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":129,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.92,"TPM_sd":5.32,"TPM_min":2.63,"TPM_25th_percentile":9.29,"TPM_median":12.46,"TPM_75th_percentile":16.23,"TPM_max":26.87},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.19,"TPM_sd":2.95,"TPM_min":1.88,"TPM_25th_percentile":3.22,"TPM_median":4.52,"TPM_75th_percentile":5.92,"TPM_max":12.81},{"x_label":"Non-germinomatous germ cell tumor  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 4)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Non-germinomatous germ cell tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0020580","MONDO":"MONDO_0020580","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.25,"TPM_sd":12.69,"TPM_min":2.98,"TPM_25th_percentile":3.02,"TPM_median":8.05,"TPM_75th_percentile":17.28,"TPM_max":29.89},{"x_label":"Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 36)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":36,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Oligodendroglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0000632","MONDO":"MONDO_0016695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.26,"TPM_sd":6.78,"TPM_min":6.48,"TPM_25th_percentile":9.19,"TPM_median":11.63,"TPM_75th_percentile":14.15,"TPM_max":36.92},{"x_label":"Osteosarcoma  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 87)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":87,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Osteosarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000637","MONDO":"MONDO_0009807","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.68,"TPM_sd":3.32,"TPM_min":1.24,"TPM_25th_percentile":4.48,"TPM_median":6.13,"TPM_75th_percentile":8.12,"TPM_max":23.42},{"x_label":"Pilocytic astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 7)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pilocytic astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016691","MONDO":"MONDO_0016691","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.39,"TPM_sd":2.1,"TPM_min":3.12,"TPM_25th_percentile":5.06,"TPM_median":6.44,"TPM_75th_percentile":8.13,"TPM_max":8.8},{"x_label":"Pineoblastoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pineoblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000475","MONDO":"MONDO_0016722","GTEx_tissue_subgroup_UBERON":"","TPM_mean":37.43,"TPM_sd":43.6,"TPM_min":3.69,"TPM_25th_percentile":7.42,"TPM_median":12.5,"TPM_75th_percentile":78.61,"TPM_max":102.03},{"x_label":"Pleomorphic xanthoastrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 3)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pleomorphic xanthoastrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016690","MONDO":"MONDO_0016690","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.64,"TPM_sd":1.81,"TPM_min":5.26,"TPM_25th_percentile":5.62,"TPM_median":5.98,"TPM_75th_percentile":7.34,"TPM_max":8.69},{"x_label":"Rhabdoid tumor of the kidney  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 64)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":64,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Rhabdoid tumor of the kidney","GTEx_tissue_subgroup":"","EFO":"EFO_1000512","MONDO":"MONDO_0002729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.24,"TPM_sd":2.84,"TPM_min":2.37,"TPM_25th_percentile":4.24,"TPM_median":5.76,"TPM_75th_percentile":7.42,"TPM_max":21.35},{"x_label":"Sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 7)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.58,"TPM_sd":2.1,"TPM_min":2.58,"TPM_25th_percentile":4.04,"TPM_median":6.13,"TPM_75th_percentile":6.89,"TPM_max":8.45},{"x_label":"Schwannoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 23)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":23,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Schwannoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000693","MONDO":"MONDO_0002546","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.55,"TPM_sd":2.79,"TPM_min":3.28,"TPM_25th_percentile":4.52,"TPM_median":5.44,"TPM_75th_percentile":8.75,"TPM_max":13.09},{"x_label":"Subependymal Giant Cell Astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Subependymal Giant Cell Astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016693","MONDO":"MONDO_0016693","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.74,"TPM_sd":1.1,"TPM_min":3.48,"TPM_25th_percentile":3.93,"TPM_median":4.5,"TPM_75th_percentile":4.83,"TPM_max":6.99},{"x_label":"Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary Tumors, N = 6)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Teratoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0002601","MONDO":"MONDO_0002601","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.96,"TPM_sd":6.22,"TPM_min":3,"TPM_25th_percentile":5.51,"TPM_median":9.03,"TPM_75th_percentile":13.71,"TPM_max":19.09},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary Tumors, N = 124)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":124,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0006058","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":12.31,"TPM_sd":5.3,"TPM_min":2.45,"TPM_25th_percentile":8.68,"TPM_median":11.61,"TPM_75th_percentile":15.03,"TPM_max":34.82},{"x_label":"Acute Myeloid Leukemia  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 147)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":147,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":13.53,"TPM_sd":4.17,"TPM_min":3.81,"TPM_25th_percentile":10.57,"TPM_median":13.44,"TPM_75th_percentile":15.94,"TPM_max":26.08},{"x_label":"Adrenocortical Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 77)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":77,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Adrenocortical Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000796","MONDO":"MONDO_0006639","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.93,"TPM_sd":1.44,"TPM_min":0.19,"TPM_25th_percentile":1.8,"TPM_median":2.89,"TPM_75th_percentile":4.04,"TPM_max":5.73},{"x_label":"Bladder Urothelial Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 405)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":405,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Bladder Urothelial Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0006544","MONDO":"MONDO_0005611","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.47,"TPM_sd":6.86,"TPM_min":0.8,"TPM_25th_percentile":3.31,"TPM_median":4.52,"TPM_75th_percentile":5.93,"TPM_max":119.69},{"x_label":"Breast Invasive Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 1088)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":1088,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Breast Invasive Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000307","MONDO":"MONDO_0006256","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.26,"TPM_sd":4.36,"TPM_min":0.67,"TPM_25th_percentile":3.9,"TPM_median":5.33,"TPM_75th_percentile":7.49,"TPM_max":52.19},{"x_label":"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 304)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":304,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000162","MONDO":"MONDO_0006143","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.72,"TPM_sd":1.63,"TPM_min":0.8,"TPM_25th_percentile":2.53,"TPM_median":3.5,"TPM_75th_percentile":4.59,"TPM_max":11.21},{"x_label":"Cholangiocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 35)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":35,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Cholangiocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0005221","MONDO":"MONDO_0019087","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.39,"TPM_sd":1.66,"TPM_min":1.72,"TPM_25th_percentile":3.02,"TPM_median":4.18,"TPM_75th_percentile":5.53,"TPM_max":9.2},{"x_label":"Chromophobe renal cell carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 65)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":65,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Chromophobe renal cell carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000335","MONDO":"MONDO_0017885","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.16,"TPM_sd":1.8,"TPM_min":1.08,"TPM_25th_percentile":2.66,"TPM_median":3.91,"TPM_75th_percentile":5.62,"TPM_max":8.83},{"x_label":"Colon Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 288)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":288,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Colon Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1001949","MONDO":"MONDO_0002271","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.67,"TPM_sd":2.29,"TPM_min":1.3,"TPM_25th_percentile":2.62,"TPM_median":3.24,"TPM_75th_percentile":4.18,"TPM_max":23.09},{"x_label":"Cutaneous Melanoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 102)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":102,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Cutaneous Melanoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000389","MONDO":"MONDO_0005012","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.25,"TPM_sd":2.49,"TPM_min":0.4,"TPM_25th_percentile":2.43,"TPM_median":4.09,"TPM_75th_percentile":5.51,"TPM_max":11.92},{"x_label":"Esophageal Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 158)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":158,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Esophageal Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002916","MONDO":"MONDO_0019086","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.63,"TPM_sd":2.28,"TPM_min":1.9,"TPM_25th_percentile":3.94,"TPM_median":5.2,"TPM_75th_percentile":7.09,"TPM_max":16.41},{"x_label":"Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 152)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":152,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Glioblastoma Multiforme","GTEx_tissue_subgroup":"","EFO":"EFO_0000519","MONDO":"MONDO_0018177","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.14,"TPM_sd":1.52,"TPM_min":0.85,"TPM_25th_percentile":3.01,"TPM_median":4.01,"TPM_75th_percentile":4.99,"TPM_max":9.03},{"x_label":"Head and Neck Squamous Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 498)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":498,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Head and Neck Squamous Cell Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000181","MONDO":"MONDO_0010150","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.22,"TPM_sd":1.7,"TPM_min":0.42,"TPM_25th_percentile":2.13,"TPM_median":2.92,"TPM_75th_percentile":4,"TPM_max":20.65},{"x_label":"Hepatocellular Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 369)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":369,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Hepatocellular Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000182","MONDO":"MONDO_0007256","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.17,"TPM_sd":1.21,"TPM_min":0.44,"TPM_25th_percentile":1.29,"TPM_median":1.89,"TPM_75th_percentile":2.75,"TPM_max":8.36},{"x_label":"Low-grade glioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 507)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":507,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.6,"TPM_sd":1.98,"TPM_min":1.79,"TPM_25th_percentile":4.16,"TPM_median":5.37,"TPM_75th_percentile":6.73,"TPM_max":13.23},{"x_label":"Lung Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 510)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":510,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Lung Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000571","MONDO":"MONDO_0005061","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.01,"TPM_sd":2.86,"TPM_min":0.7,"TPM_25th_percentile":3.43,"TPM_median":4.34,"TPM_75th_percentile":5.91,"TPM_max":36.96},{"x_label":"Lung Squamous Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 498)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":498,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Lung Squamous Cell Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000708","MONDO":"MONDO_0005097","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.96,"TPM_sd":2.16,"TPM_min":0.65,"TPM_25th_percentile":3.47,"TPM_median":4.6,"TPM_75th_percentile":6.05,"TPM_max":14.55},{"x_label":"Lymphoid Neoplasm Diffuse Large B-cell Lymphoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 47)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":47,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Lymphoid Neoplasm Diffuse Large B-cell Lymphoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000403","MONDO":"MONDO_0018905","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.33,"TPM_sd":1.6,"TPM_min":0.92,"TPM_25th_percentile":2.19,"TPM_median":3.02,"TPM_75th_percentile":4.27,"TPM_max":8.57},{"x_label":"Mesothelioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 86)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":86,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Mesothelioma","GTEx_tissue_subgroup":"","EFO":"EFO_0000588","MONDO":"MONDO_0005065","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.46,"TPM_sd":1.4,"TPM_min":1.24,"TPM_25th_percentile":2.53,"TPM_median":3.38,"TPM_75th_percentile":4.1,"TPM_max":10.2},{"x_label":"Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 373)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":373,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Ovarian Serous Cystadenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000043","MONDO":"MONDO_0006046","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.23,"TPM_sd":1.58,"TPM_min":1.1,"TPM_25th_percentile":3.18,"TPM_median":4.02,"TPM_75th_percentile":5,"TPM_max":11.23},{"x_label":"Pancreatic Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 177)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":177,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Pancreatic Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000044","MONDO":"MONDO_0006047","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.15,"TPM_sd":1.51,"TPM_min":0.6,"TPM_25th_percentile":3.18,"TPM_median":3.99,"TPM_75th_percentile":4.72,"TPM_max":11.11},{"x_label":"Pheochromocytoma and Paraganglioma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 177)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":177,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Pheochromocytoma and Paraganglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0020005","MONDO":"MONDO_0035540","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.33,"TPM_sd":2.42,"TPM_min":1.34,"TPM_25th_percentile":3.74,"TPM_median":5.11,"TPM_75th_percentile":6.4,"TPM_max":18.75},{"x_label":"Prostate Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 494)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":494,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Prostate Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000673","MONDO":"MONDO_0005082","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.95,"TPM_sd":4.01,"TPM_min":1.23,"TPM_25th_percentile":5.08,"TPM_median":6.44,"TPM_75th_percentile":8.21,"TPM_max":66.75},{"x_label":"Rectum Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 92)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":92,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Rectum Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0005631","MONDO":"MONDO_0002169","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.65,"TPM_sd":1.16,"TPM_min":0.92,"TPM_25th_percentile":2.86,"TPM_median":3.46,"TPM_75th_percentile":4.34,"TPM_max":6.54},{"x_label":"Renal Clear Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 527)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":527,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Renal Clear Cell Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000349","MONDO":"MONDO_0005005","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.58,"TPM_sd":2.6,"TPM_min":0.53,"TPM_25th_percentile":3.82,"TPM_median":5.34,"TPM_75th_percentile":7.05,"TPM_max":23.57},{"x_label":"Renal Papillary Cell Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 286)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":286,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Renal Papillary Cell Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000640","MONDO":"MONDO_0017884","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.91,"TPM_sd":2.46,"TPM_min":0.81,"TPM_25th_percentile":3.14,"TPM_median":4.5,"TPM_75th_percentile":6.14,"TPM_max":14.36},{"x_label":"Sarcoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 258)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":258,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.43,"TPM_sd":2.19,"TPM_min":1.08,"TPM_25th_percentile":2.92,"TPM_median":4.11,"TPM_75th_percentile":5.44,"TPM_max":19.22},{"x_label":"Stomach Adenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 373)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":373,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Stomach Adenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000503","MONDO":"MONDO_0005036","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.55,"TPM_sd":2.04,"TPM_min":1.21,"TPM_25th_percentile":3.13,"TPM_median":4.23,"TPM_75th_percentile":5.55,"TPM_max":16.65},{"x_label":"Testicular Germ Cell Tumor  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 148)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":148,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Testicular Germ Cell Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1000566","MONDO":"MONDO_0010108","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.82,"TPM_sd":2.17,"TPM_min":0.72,"TPM_25th_percentile":3.24,"TPM_median":4.39,"TPM_75th_percentile":5.93,"TPM_max":11.44},{"x_label":"Thymoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 118)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":118,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Thymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000581","MONDO":"MONDO_0006456","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.71,"TPM_sd":2.43,"TPM_min":0.56,"TPM_25th_percentile":3.16,"TPM_median":4.37,"TPM_75th_percentile":5.81,"TPM_max":14.37},{"x_label":"Thyroid Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 501)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":501,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Thyroid Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002892","MONDO":"MONDO_0015075","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.63,"TPM_sd":2.38,"TPM_min":0.54,"TPM_25th_percentile":5.27,"TPM_median":6.5,"TPM_75th_percentile":8.01,"TPM_max":27.83},{"x_label":"Uterine Carcinosarcoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 56)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":56,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Uterine Carcinosarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000613","MONDO":"MONDO_0006485","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.27,"TPM_sd":1.89,"TPM_min":1.33,"TPM_25th_percentile":2.9,"TPM_median":3.91,"TPM_75th_percentile":5.31,"TPM_max":10.01},{"x_label":"Uterine Corpus Endometrial Carcinoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 178)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":178,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Uterine Corpus Endometrial Carcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_0007532","MONDO":"MONDO_0000553","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.41,"TPM_sd":4.39,"TPM_min":0.58,"TPM_25th_percentile":2.7,"TPM_median":3.8,"TPM_75th_percentile":4.96,"TPM_max":44.36},{"x_label":"Uveal Melanoma  (Dataset = TCGA, Specimen = TCGA Primary Tumors, N = 79)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":79,"Gene_Ensembl_ID":"ENSG00000157764","Gene_symbol":"BRAF","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TCGA","Disease":"Uveal Melanoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000616","MONDO":"MONDO_0006486","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.44,"TPM_sd":1.4,"TPM_min":0.36,"TPM_25th_percentile":1.32,"TPM_median":2.25,"TPM_75th_percentile":3.29,"TPM_max":7.73}]